Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESVEM
NCT00000518Phase 3Completed
- Sponsor
- University of Utah
- Start
- Jul 1985
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, open-label trial of imipramine, mexiletine, pirmenol, procainamide, propafenone and 2 more in ventricular tachycardia (VT), ventricular fibrillation (VF) and cardiac arrest (SCA) (2 arms), sponsored by University of Utah. Primary endpoint: Time to recurrence of arrhythmia at 6 years. Started Jul 1985; status: completed.
02
Drugs
imipraminemexiletinepirmenolprocainamidepropafenone
03
Conditions
ventricular tachycardia (VT)ventricular fibrillation (VF)cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT00000518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000518.